APA

Ahmed K. A., Abuodeh Y. A., Echevarria M. I., Arrington J. A., Stallworth D. G., Hogue C., Naghavi A. O., Kim S., Kim Y., Patel B. G., Sarangkasiri S., Johnstone P. A. S., Sahebjam S., Khushalani N. I., Forsyth P. A., Harrison L. B., Yu M., Etame A. B. & Caudell J. J. (20171226). Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Ahmed K A, Abuodeh Y A, Echevarria M I, Arrington J A, Stallworth D G, Hogue C, Naghavi A O, Kim S, Kim Y, Patel B G, Sarangkasiri S, Johnstone P A S, Sahebjam S, Khushalani N I, Forsyth P A, Harrison L B, Yu M, Etame A B and Caudell J J. 20171226. Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Ahmed K. A., Abuodeh Y. A., Echevarria M. I., Arrington J. A., Stallworth D. G., Hogue C., Naghavi A. O., Kim S., Kim Y., Patel B. G., Sarangkasiri S., Johnstone P. A. S., Sahebjam S., Khushalani N. I., Forsyth P. A., Harrison L. B., Yu M., Etame A. B. and Caudell J. J. (20171226). Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Ahmed K A, Abuodeh Y A, Echevarria M I, Arrington J A, Stallworth D G, Hogue C, Naghavi A O, Kim S, Kim Y, Patel B G, Sarangkasiri S, Johnstone P A S, Sahebjam S, Khushalani N I, Forsyth P A, Harrison L B, Yu M, Etame A B and Caudell J J. Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy. : Annals of oncology : official journal of the European Society for Medical Oncology. 20171226.